Index by author

01 June 2009; volume 33, issue 6

A

  1. Aerts, J. G.

    1. van Heemst, R. C. et al "Hypersensitivity pneumonitis caused by occupational exposure to phytase." European Respiratory Journal 33.6 (2009): 1507-1509. Web. 16 Oct. 2019.

  2. Anagnostakos, T.

    1. Pecchiari, M. et al "Effect of heliox breathing on flow limitation in chronic heart failure patients." European Respiratory Journal 33.6 (2009): 1367-1373. Web. 16 Oct. 2019.

  3. Anderson, S. T.

    1. Kampmann, B. et al "Interferon-γ release assays do not identify more children with active tuberculosis than the tuberculin skin test." European Respiratory Journal 33.6 (2009): 1374-1382. Web. 16 Oct. 2019.

  4. Arkadopoulos, N. P.

    1. Kostopanagiotou, G. G. et al "Desferrioxamine attenuates minor lung injury following surgical acute liver failure." European Respiratory Journal 33.6 (2009): 1429-1436. Web. 16 Oct. 2019.

  5. Aubier, M.

    1. Khaldi, H. et al "Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease." European Respiratory Journal 33.6 (2009): 1498-1502. Web. 16 Oct. 2019.
    2. Borie, R. et al "Rituximab therapy in autoimmune pulmonary alveolar proteinosis." European Respiratory Journal 33.6 (2009): 1503-1506. Web. 16 Oct. 2019.

  6. Avila, L.

    1. Sharma, S. et al "Association of VEGF polymorphisms with childhood asthma, lung function and airway responsiveness." European Respiratory Journal 33.6 (2009): 1287-1294. Web. 16 Oct. 2019.

B

  1. Baldassarre, S.

    1. Michils, A. et al "Exhaled nitric oxide as a marker of asthma control in smoking patients." European Respiratory Journal 33.6 (2009): 1295-1301. Web. 16 Oct. 2019.

  2. Bando, M.

    1. Mato, N. et al "Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury." European Respiratory Journal 33.6 (2009): 1415-1428. Web. 16 Oct. 2019.

  3. Barisione, G.

    1. Barisione, G. et al "How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1." European Respiratory Journal 33.6 (2009): 1396-1402. Web. 16 Oct. 2019.

  4. Barreiro, E.

    1. Marin-Corral, J. et al "Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients." European Respiratory Journal 33.6 (2009): 1309-1319. Web. 16 Oct. 2019.

  5. Bartolini, S.

    1. Barisione, G. et al "How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1." European Respiratory Journal 33.6 (2009): 1396-1402. Web. 16 Oct. 2019.

  6. Bathoorn, E.

    1. Bathoorn, E. et al "A turbulent cause of bilateral pneumonia." European Respiratory Journal 33.6 (2009): 1513-1516. Web. 16 Oct. 2019.

  7. Belderbos, H. N. A.

    1. van Heemst, R. C. et al "Hypersensitivity pneumonitis caused by occupational exposure to phytase." European Respiratory Journal 33.6 (2009): 1507-1509. Web. 16 Oct. 2019.

  8. Berdel, W. E.

    1. Kreuter, M. et al "Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment." European Respiratory Journal 33.6 (2009): 1383-1388. Web. 16 Oct. 2019.

  9. Blasi, F.

    1. Blasi, F. et al "Steps forward in LRTI and tuberculosis: update from the ERS Respiratory Infections Assembly." European Respiratory Journal 33.6 (2009): 1448-1453. Web. 16 Oct. 2019.

  10. Boersma, W.

    1. Blasi, F. et al "Steps forward in LRTI and tuberculosis: update from the ERS Respiratory Infections Assembly." European Respiratory Journal 33.6 (2009): 1448-1453. Web. 16 Oct. 2019.

  11. Boersma, W. G.

    1. Bathoorn, E. et al "A turbulent cause of bilateral pneumonia." European Respiratory Journal 33.6 (2009): 1513-1516. Web. 16 Oct. 2019.

  12. Bolliger, C. T.

    1. Koegelenberg, C. F. N. et al "Diagnostic yield and safety of ultrasound-assisted biopsies in superior vena cava syndrome." European Respiratory Journal 33.6 (2009): 1389-1395. Web. 16 Oct. 2019.

  13. Borie, R.

    1. Borie, R. et al "Rituximab therapy in autoimmune pulmonary alveolar proteinosis." European Respiratory Journal 33.6 (2009): 1503-1506. Web. 16 Oct. 2019.

  14. Boulet, L. P.

    1. Davis, B. E. et al "Single-dose desloratadine and montelukast and allergen-induced late airway responses." European Respiratory Journal 33.6 (2009): 1302-1308. Web. 16 Oct. 2019.

  15. Brambilla, E.

    1. Brambilla, E., and A. Gazdar. "Pathogenesis of lung cancer signalling pathways: roadmap for therapies." European Respiratory Journal 33.6 (2009): 1485-1497. Web. 16 Oct. 2019.

  16. Brundyn, K.

    1. Koegelenberg, C. F. N. et al "Diagnostic yield and safety of ultrasound-assisted biopsies in superior vena cava syndrome." European Respiratory Journal 33.6 (2009): 1389-1395. Web. 16 Oct. 2019.

  17. Brusasco, V.

    1. Barisione, G. et al "How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1." European Respiratory Journal 33.6 (2009): 1396-1402. Web. 16 Oct. 2019.

C

  1. Calabrò, E.

    1. Sverzellati, N. et al "Sex differences in emphysema phenotype in smokers without airflow obstruction." European Respiratory Journal 33.6 (2009): 1320-1328. Web. 16 Oct. 2019.

  2. Calverley, P. M. A.

    1. Dellacà, R. L. et al "Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD." European Respiratory Journal 33.6 (2009): 1329-1337. Web. 16 Oct. 2019.

  3. Celedón, J. C.

    1. Sharma, S. et al "Association of VEGF polymorphisms with childhood asthma, lung function and airway responsiveness." European Respiratory Journal 33.6 (2009): 1287-1294. Web. 16 Oct. 2019.

  4. Cockcroft, D. W.

    1. Davis, B. E. et al "Single-dose desloratadine and montelukast and allergen-induced late airway responses." European Respiratory Journal 33.6 (2009): 1302-1308. Web. 16 Oct. 2019.

  5. Copello, F.

    1. Barisione, G. et al "How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1." European Respiratory Journal 33.6 (2009): 1396-1402. Web. 16 Oct. 2019.

  6. Cosentini, R.

    1. Blasi, F. et al "Steps forward in LRTI and tuberculosis: update from the ERS Respiratory Infections Assembly." European Respiratory Journal 33.6 (2009): 1448-1453. Web. 16 Oct. 2019.

  7. Crestani, B.

    1. Khaldi, H. et al "Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease." European Respiratory Journal 33.6 (2009): 1498-1502. Web. 16 Oct. 2019.
    2. Borie, R. et al "Rituximab therapy in autoimmune pulmonary alveolar proteinosis." European Respiratory Journal 33.6 (2009): 1503-1506. Web. 16 Oct. 2019.

  8. Crimi, E.

    1. Barisione, G. et al "How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1." European Respiratory Journal 33.6 (2009): 1396-1402. Web. 16 Oct. 2019.

  9. Crook, A. M.

    1. Kampmann, B. et al "Interferon-γ release assays do not identify more children with active tuberculosis than the tuberculin skin test." European Respiratory Journal 33.6 (2009): 1374-1382. Web. 16 Oct. 2019.

D

  1. D'Angelo, E.

    1. Pecchiari, M. et al "Effect of heliox breathing on flow limitation in chronic heart failure patients." European Respiratory Journal 33.6 (2009): 1367-1373. Web. 16 Oct. 2019.

  2. Danel, C.

    1. Khaldi, H. et al "Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease." European Respiratory Journal 33.6 (2009): 1498-1502. Web. 16 Oct. 2019.

  3. Davis, B. E.

    1. Davis, B. E. et al "Single-dose desloratadine and montelukast and allergen-induced late airway responses." European Respiratory Journal 33.6 (2009): 1302-1308. Web. 16 Oct. 2019.

  4. Dawkins, C. L.

    1. Dawkins, P. A. et al "Rate of progression of lung function impairment in α1-antitrypsin deficiency." European Respiratory Journal 33.6 (2009): 1338-1344. Web. 16 Oct. 2019.

  5. Dawkins, P. A.

    1. Dawkins, P. A. et al "Rate of progression of lung function impairment in α1-antitrypsin deficiency." European Respiratory Journal 33.6 (2009): 1338-1344. Web. 16 Oct. 2019.

  6. Debray, M-P.

    1. Borie, R. et al "Rituximab therapy in autoimmune pulmonary alveolar proteinosis." European Respiratory Journal 33.6 (2009): 1503-1506. Web. 16 Oct. 2019.

  7. Debray, M. P.

    1. Khaldi, H. et al "Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease." European Respiratory Journal 33.6 (2009): 1498-1502. Web. 16 Oct. 2019.

  8. Decker, P. A.

    1. Maldonado, F. et al "Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage." European Respiratory Journal 33.6 (2009): 1361-1366. Web. 16 Oct. 2019.

  9. de Jong, L.

    1. van Heemst, R. C. et al "Hypersensitivity pneumonitis caused by occupational exposure to phytase." European Respiratory Journal 33.6 (2009): 1507-1509. Web. 16 Oct. 2019.

  10. Dellacà, R. L.

    1. Dellacà, R. L. et al "Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD." European Respiratory Journal 33.6 (2009): 1329-1337. Web. 16 Oct. 2019.

  11. Deng, C.

    1. Dirksen, A. et al "Exploring the role of CT densitometry: a randomised study of augmentation therapy in α1-antitrypsin deficiency." European Respiratory Journal 33.6 (2009): 1345-1353. Web. 16 Oct. 2019.

  12. Derom, E.

    1. Derom, E. et al "Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma." European Respiratory Journal 33.6 (2009): 1277-1286. Web. 16 Oct. 2019.

  13. Deschesnes, F.

    1. Davis, B. E. et al "Single-dose desloratadine and montelukast and allergen-induced late airway responses." European Respiratory Journal 33.6 (2009): 1302-1308. Web. 16 Oct. 2019.

  14. Diacon, A. H.

    1. Koegelenberg, C. F. N. et al "Diagnostic yield and safety of ultrasound-assisted biopsies in superior vena cava syndrome." European Respiratory Journal 33.6 (2009): 1389-1395. Web. 16 Oct. 2019.

  15. Dirksen, A.

    1. Dirksen, A. et al "Exploring the role of CT densitometry: a randomised study of augmentation therapy in α1-antitrypsin deficiency." European Respiratory Journal 33.6 (2009): 1345-1353. Web. 16 Oct. 2019.

  16. Djamin, R. S.

    1. van Heemst, R. C. et al "Hypersensitivity pneumonitis caused by occupational exposure to phytase." European Respiratory Journal 33.6 (2009): 1507-1509. Web. 16 Oct. 2019.

  17. Dorscheid, D. R.

    1. MacRedmond, R., G. K. Singhera, and D. R. Dorscheid. "Erythropoietin inhibits respiratory epithelial cell apoptosis in a model of acute lung injury." European Respiratory Journal 33.6 (2009): 1403-1414. Web. 16 Oct. 2019.

  18. Drobniewski, F.

    1. Lange, C. et al "Interferon-γ release assays for the diagnosis of active tuberculosis: sensible or silly?." European Respiratory Journal 33.6 (2009): 1250-1253. Web. 16 Oct. 2019.

  19. Duffy, N.

    1. Dellacà, R. L. et al "Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD." European Respiratory Journal 33.6 (2009): 1329-1337. Web. 16 Oct. 2019.

E

  1. El Benna, J.

    1. Khaldi, H. et al "Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease." European Respiratory Journal 33.6 (2009): 1498-1502. Web. 16 Oct. 2019.

  2. Engelstätter, R.

    1. Derom, E. et al "Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma." European Respiratory Journal 33.6 (2009): 1277-1286. Web. 16 Oct. 2019.

  3. Enoz, M.

    1. Enoz, M., and H. M. Inancli. "CPAP and measures of cardiovascular risks in patients with OSAS." European Respiratory Journal 33.6 (2009): 1520. Web. 16 Oct. 2019.

  4. Ewig, S.

    1. Woodhead, M. A., A. Torres, and S. Ewig. "Pigs might fly." European Respiratory Journal 33.6 (2009): 1241-1243. Web. 16 Oct. 2019.

F

  1. Fabre, A.

    1. Khaldi, H. et al "Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease." European Respiratory Journal 33.6 (2009): 1498-1502. Web. 16 Oct. 2019.

  2. Farncombe, T. H.

    1. Jobse, B. N. et al "Evaluation of allergic lung inflammation by computed tomography in a rat model in vivo." European Respiratory Journal 33.6 (2009): 1437-1447. Web. 16 Oct. 2019.

  3. Fischaleck, A.

    1. Kreuter, M. et al "Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment." European Respiratory Journal 33.6 (2009): 1383-1388. Web. 16 Oct. 2019.

  4. Forsberg, B.

    1. Modig, L. et al "Vehicle exhaust outside the home and onset of asthma among adults." European Respiratory Journal 33.6 (2009): 1261-1267. Web. 16 Oct. 2019.

  5. Fujii, M.

    1. Mato, N. et al "Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury." European Respiratory Journal 33.6 (2009): 1415-1428. Web. 16 Oct. 2019.

G

  1. Gauvreau, G. M.

    1. Davis, B. E. et al "Single-dose desloratadine and montelukast and allergen-induced late airway responses." European Respiratory Journal 33.6 (2009): 1302-1308. Web. 16 Oct. 2019.

  2. Gazdar, A.

    1. Brambilla, E., and A. Gazdar. "Pathogenesis of lung cancer signalling pathways: roadmap for therapies." European Respiratory Journal 33.6 (2009): 1485-1497. Web. 16 Oct. 2019.

  3. Gea, J.

    1. Marin-Corral, J. et al "Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients." European Respiratory Journal 33.6 (2009): 1309-1319. Web. 16 Oct. 2019.

  4. Gerss, J.

    1. Kreuter, M. et al "Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment." European Respiratory Journal 33.6 (2009): 1383-1388. Web. 16 Oct. 2019.

  5. Golpon, H.

    1. Hoeper, M. M. et al "Severe hepatitis associated with sitaxentan and response to glucocorticoid therapy." European Respiratory Journal 33.6 (2009): 1518-1519. Web. 16 Oct. 2019.

  6. Goncharova, S.

    1. Jobse, B. N. et al "Evaluation of allergic lung inflammation by computed tomography in a rat model in vivo." European Respiratory Journal 33.6 (2009): 1437-1447. Web. 16 Oct. 2019.

  7. Gordon, A.

    1. Kampmann, B. et al "Interferon-γ release assays do not identify more children with active tuberculosis than the tuberculin skin test." European Respiratory Journal 33.6 (2009): 1374-1382. Web. 16 Oct. 2019.

  8. Gougerot-Pocidalo, M-A.

    1. Khaldi, H. et al "Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease." European Respiratory Journal 33.6 (2009): 1498-1502. Web. 16 Oct. 2019.

H

  1. Hakamata, Y.

    1. Mato, N. et al "Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury." European Respiratory Journal 33.6 (2009): 1415-1428. Web. 16 Oct. 2019.

  2. Han, Z-Y.

    1. Jing, Z-C. et al "Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension." European Respiratory Journal 33.6 (2009): 1354-1360. Web. 16 Oct. 2019.

  3. Hayakawa, M.

    1. Mato, N. et al "Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury." European Respiratory Journal 33.6 (2009): 1415-1428. Web. 16 Oct. 2019.

  4. Heinecke, A.

    1. Kreuter, M. et al "Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment." European Respiratory Journal 33.6 (2009): 1383-1388. Web. 16 Oct. 2019.

  5. Heitbrink, M. A.

    1. Bathoorn, E. et al "A turbulent cause of bilateral pneumonia." European Respiratory Journal 33.6 (2009): 1513-1516. Web. 16 Oct. 2019.

  6. Hoeper, M. M.

    1. Hoeper, M. M. et al "Severe hepatitis associated with sitaxentan and response to glucocorticoid therapy." European Respiratory Journal 33.6 (2009): 1518-1519. Web. 16 Oct. 2019.

  7. Humbert, M.

    1. Khaldi, H. et al "Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease." European Respiratory Journal 33.6 (2009): 1498-1502. Web. 16 Oct. 2019.

  8. Hussain, S. N. A.

    1. Marin-Corral, J. et al "Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients." European Respiratory Journal 33.6 (2009): 1309-1319. Web. 16 Oct. 2019.

  9. Hutton, A-M.

    1. Kampmann, B. et al "Interferon-γ release assays do not identify more children with active tuberculosis than the tuberculin skin test." European Respiratory Journal 33.6 (2009): 1374-1382. Web. 16 Oct. 2019.

I

  1. Illamperuma, C.

    1. Davis, B. E. et al "Single-dose desloratadine and montelukast and allergen-induced late airway responses." European Respiratory Journal 33.6 (2009): 1302-1308. Web. 16 Oct. 2019.

  2. Inancli, H. M.

    1. Enoz, M., and H. M. Inancli. "CPAP and measures of cardiovascular risks in patients with OSAS." European Respiratory Journal 33.6 (2009): 1520. Web. 16 Oct. 2019.

J

  1. Jacobsen, G.

    1. Jacobsen, G. et al "Increased incidence of respiratory symptoms among female woodworkers exposed to dry wood." European Respiratory Journal 33.6 (2009): 1268-1276. Web. 16 Oct. 2019.

  2. Janson, C.

    1. Modig, L. et al "Vehicle exhaust outside the home and onset of asthma among adults." European Respiratory Journal 33.6 (2009): 1261-1267. Web. 16 Oct. 2019.

  3. Jarvholm, B.

    1. Modig, L. et al "Vehicle exhaust outside the home and onset of asthma among adults." European Respiratory Journal 33.6 (2009): 1261-1267. Web. 16 Oct. 2019.

  4. Jiang, X.

    1. Jing, Z-C. et al "Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension." European Respiratory Journal 33.6 (2009): 1354-1360. Web. 16 Oct. 2019.

  5. Jing, Z-C.

    1. Jing, Z-C. et al "Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension." European Respiratory Journal 33.6 (2009): 1354-1360. Web. 16 Oct. 2019.

  6. Jobse, B. N.

    1. Jobse, B. N. et al "Evaluation of allergic lung inflammation by computed tomography in a rat model in vivo." European Respiratory Journal 33.6 (2009): 1437-1447. Web. 16 Oct. 2019.

  7. Johnson, J. R.

    1. Jobse, B. N. et al "Evaluation of allergic lung inflammation by computed tomography in a rat model in vivo." European Respiratory Journal 33.6 (2009): 1437-1447. Web. 16 Oct. 2019.

  8. Joos, G. F.

    1. Derom, E. et al "Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma." European Respiratory Journal 33.6 (2009): 1277-1286. Web. 16 Oct. 2019.

  9. Jordana, M.

    1. Jobse, B. N. et al "Evaluation of allergic lung inflammation by computed tomography in a rat model in vivo." European Respiratory Journal 33.6 (2009): 1437-1447. Web. 16 Oct. 2019.

  10. Junker, K.

    1. Kreuter, M. et al "Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment." European Respiratory Journal 33.6 (2009): 1383-1388. Web. 16 Oct. 2019.

K

  1. Kalimeris, K. A.

    1. Kostopanagiotou, G. G. et al "Desferrioxamine attenuates minor lung injury following surgical acute liver failure." European Respiratory Journal 33.6 (2009): 1429-1436. Web. 16 Oct. 2019.

  2. Kampmann, B.

    1. Kampmann, B. et al "Interferon-γ release assays do not identify more children with active tuberculosis than the tuberculin skin test." European Respiratory Journal 33.6 (2009): 1374-1382. Web. 16 Oct. 2019.

  3. Kannengiesser, C.

    1. Khaldi, H. et al "Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease." European Respiratory Journal 33.6 (2009): 1498-1502. Web. 16 Oct. 2019.

  4. Kaufman, J-M.

    1. Derom, E. et al "Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma." European Respiratory Journal 33.6 (2009): 1277-1286. Web. 16 Oct. 2019.

  5. Khaldi, H.

    1. Khaldi, H. et al "Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease." European Respiratory Journal 33.6 (2009): 1498-1502. Web. 16 Oct. 2019.

  6. Klanderman, B. J.

    1. Sharma, S. et al "Association of VEGF polymorphisms with childhood asthma, lung function and airway responsiveness." European Respiratory Journal 33.6 (2009): 1287-1294. Web. 16 Oct. 2019.

  7. Kobayashi, E.

    1. Mato, N. et al "Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury." European Respiratory Journal 33.6 (2009): 1415-1428. Web. 16 Oct. 2019.

  8. Koegelenberg, C. F. N.

    1. Koegelenberg, C. F. N. et al "Diagnostic yield and safety of ultrasound-assisted biopsies in superior vena cava syndrome." European Respiratory Journal 33.6 (2009): 1389-1395. Web. 16 Oct. 2019.

  9. Kostopanagiotou, G. G.

    1. Kostopanagiotou, G. G. et al "Desferrioxamine attenuates minor lung injury following surgical acute liver failure." European Respiratory Journal 33.6 (2009): 1429-1436. Web. 16 Oct. 2019.

  10. Koutsoukou, A.

    1. Pecchiari, M. et al "Effect of heliox breathing on flow limitation in chronic heart failure patients." European Respiratory Journal 33.6 (2009): 1367-1373. Web. 16 Oct. 2019.

  11. Kreuter, M.

    1. Kreuter, M. et al "Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment." European Respiratory Journal 33.6 (2009): 1383-1388. Web. 16 Oct. 2019.

  12. Kropff, M.

    1. Kreuter, M. et al "Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment." European Respiratory Journal 33.6 (2009): 1383-1388. Web. 16 Oct. 2019.

  13. Kuhnigk, J-M.

    1. Sverzellati, N. et al "Sex differences in emphysema phenotype in smokers without airflow obstruction." European Respiratory Journal 33.6 (2009): 1320-1328. Web. 16 Oct. 2019.

L

  1. Labiris, R.

    1. Jobse, B. N. et al "Evaluation of allergic lung inflammation by computed tomography in a rat model in vivo." European Respiratory Journal 33.6 (2009): 1437-1447. Web. 16 Oct. 2019.

  2. Laine, C.

    1. Borie, R. et al "Rituximab therapy in autoimmune pulmonary alveolar proteinosis." European Respiratory Journal 33.6 (2009): 1503-1506. Web. 16 Oct. 2019.

  3. Lange, C.

    1. Lange, C. et al "Interferon-γ release assays for the diagnosis of active tuberculosis: sensible or silly?." European Respiratory Journal 33.6 (2009): 1250-1253. Web. 16 Oct. 2019.

  4. La Vecchia, C.

    1. Sverzellati, N. et al "Sex differences in emphysema phenotype in smokers without airflow obstruction." European Respiratory Journal 33.6 (2009): 1320-1328. Web. 16 Oct. 2019.

  5. Lavie, L.

    1. Lavie, L., and P. Lavie. "Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link." European Respiratory Journal 33.6 (2009): 1467-1484. Web. 16 Oct. 2019.

  6. Lavie, P.

    1. Lavie, L., and P. Lavie. "Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link." European Respiratory Journal 33.6 (2009): 1467-1484. Web. 16 Oct. 2019.

  7. Lekka, M. E.

    1. Kostopanagiotou, G. G. et al "Desferrioxamine attenuates minor lung injury following surgical acute liver failure." European Respiratory Journal 33.6 (2009): 1429-1436. Web. 16 Oct. 2019.

  8. Lindermann, M.

    1. Kreuter, M. et al "Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment." European Respiratory Journal 33.6 (2009): 1383-1388. Web. 16 Oct. 2019.

  9. Louis, R.

    1. Derom, E. et al "Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma." European Respiratory Journal 33.6 (2009): 1277-1286. Web. 16 Oct. 2019.
    2. Michils, A. et al "Exhaled nitric oxide as a marker of asthma control in smoking patients." European Respiratory Journal 33.6 (2009): 1295-1301. Web. 16 Oct. 2019.

  10. Louw, M.

    1. Koegelenberg, C. F. N. et al "Diagnostic yield and safety of ultrasound-assisted biopsies in superior vena cava syndrome." European Respiratory Journal 33.6 (2009): 1389-1395. Web. 16 Oct. 2019.

  11. Lv, H.

    1. Jing, Z-C. et al "Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension." European Respiratory Journal 33.6 (2009): 1354-1360. Web. 16 Oct. 2019.

M

  1. Ma, C-R.

    1. Jing, Z-C. et al "Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension." European Respiratory Journal 33.6 (2009): 1354-1360. Web. 16 Oct. 2019.

  2. MacRedmond, R.

    1. MacRedmond, R., G. K. Singhera, and D. R. Dorscheid. "Erythropoietin inhibits respiratory epithelial cell apoptosis in a model of acute lung injury." European Respiratory Journal 33.6 (2009): 1403-1414. Web. 16 Oct. 2019.

  3. Maldonado, F.

    1. Maldonado, F. et al "Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage." European Respiratory Journal 33.6 (2009): 1361-1366. Web. 16 Oct. 2019.

  4. Marchand-Adam, S.

    1. Khaldi, H. et al "Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease." European Respiratory Journal 33.6 (2009): 1498-1502. Web. 16 Oct. 2019.

  5. Marchianò, A.

    1. Sverzellati, N. et al "Sex differences in emphysema phenotype in smokers without airflow obstruction." European Respiratory Journal 33.6 (2009): 1320-1328. Web. 16 Oct. 2019.

  6. Marin-Corral, J.

    1. Marin-Corral, J. et al "Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients." European Respiratory Journal 33.6 (2009): 1309-1319. Web. 16 Oct. 2019.

  7. Martinez-Alier, N.

    1. Kampmann, B. et al "Interferon-γ release assays do not identify more children with active tuberculosis than the tuberculin skin test." European Respiratory Journal 33.6 (2009): 1374-1382. Web. 16 Oct. 2019.

  8. Mato, N.

    1. Mato, N. et al "Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury." European Respiratory Journal 33.6 (2009): 1415-1428. Web. 16 Oct. 2019.

  9. McLure, L. E. R.

    1. McLure, L. E. R., and A. J. Peacock. "Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension." European Respiratory Journal 33.6 (2009): 1454-1466. Web. 16 Oct. 2019.

  10. Mesters, R. M.

    1. Kreuter, M. et al "Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment." European Respiratory Journal 33.6 (2009): 1383-1388. Web. 16 Oct. 2019.

  11. Michils, A.

    1. Michils, A. et al "Exhaled nitric oxide as a marker of asthma control in smoking patients." European Respiratory Journal 33.6 (2009): 1295-1301. Web. 16 Oct. 2019.

  12. Migliori, G. B.

    1. Lange, C. et al "Interferon-γ release assays for the diagnosis of active tuberculosis: sensible or silly?." European Respiratory Journal 33.6 (2009): 1250-1253. Web. 16 Oct. 2019.
    2. Blasi, F. et al "Steps forward in LRTI and tuberculosis: update from the ERS Respiratory Infections Assembly." European Respiratory Journal 33.6 (2009): 1448-1453. Web. 16 Oct. 2019.

  13. Minguella, J.

    1. Marin-Corral, J. et al "Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients." European Respiratory Journal 33.6 (2009): 1309-1319. Web. 16 Oct. 2019.

  14. Miravitlles, M.

    1. Soriano, J. B., and M. Miravitlles. "Your racing horses will help you to quit: a lesson for COPD and α1-antitrypsin deficiency research." European Respiratory Journal 33.6 (2009): 1244-1246. Web. 16 Oct. 2019.

  15. Modig, L.

    1. Modig, L. et al "Vehicle exhaust outside the home and onset of asthma among adults." European Respiratory Journal 33.6 (2009): 1261-1267. Web. 16 Oct. 2019.

  16. Morrell, N. W.

    1. Sundaram, S., A. D. Tasker, and N. W. Morrell. "Familial spontaneous pneumothorax and lung cysts due to a Folliculin exon 10 mutation." European Respiratory Journal 33.6 (2009): 1510-1512. Web. 16 Oct. 2019.

  17. Murphy, A. J.

    1. Sharma, S. et al "Association of VEGF polymorphisms with childhood asthma, lung function and airway responsiveness." European Respiratory Journal 33.6 (2009): 1287-1294. Web. 16 Oct. 2019.

N

  1. Nakos, G.

    1. Kostopanagiotou, G. G. et al "Desferrioxamine attenuates minor lung injury following surgical acute liver failure." European Respiratory Journal 33.6 (2009): 1429-1436. Web. 16 Oct. 2019.

  2. Nanas, S.

    1. Pecchiari, M. et al "Effect of heliox breathing on flow limitation in chronic heart failure patients." European Respiratory Journal 33.6 (2009): 1367-1373. Web. 16 Oct. 2019.

  3. Nightingale, P. G.

    1. Dawkins, P. A. et al "Rate of progression of lung function impairment in α1-antitrypsin deficiency." European Respiratory Journal 33.6 (2009): 1338-1344. Web. 16 Oct. 2019.

O

  1. O'Byrne, P. M.

    1. Davis, B. E. et al "Single-dose desloratadine and montelukast and allergen-induced late airway responses." European Respiratory Journal 33.6 (2009): 1302-1308. Web. 16 Oct. 2019.

  2. Ohno, S.

    1. Mato, N. et al "Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury." European Respiratory Journal 33.6 (2009): 1415-1428. Web. 16 Oct. 2019.

  3. Ohto-Ozaki, H.

    1. Mato, N. et al "Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury." European Respiratory Journal 33.6 (2009): 1415-1428. Web. 16 Oct. 2019.

  4. Olsson, K. M.

    1. Hoeper, M. M. et al "Severe hepatitis associated with sitaxentan and response to glucocorticoid therapy." European Respiratory Journal 33.6 (2009): 1518-1519. Web. 16 Oct. 2019.

  5. Opitz, C. F.

    1. Opitz, C. F., and L. J. Rubin. "Acute vasodilator testing in idiopathic pulmonary arterial hypertension: must we take NO for the answer?." European Respiratory Journal 33.6 (2009): 1247-1249. Web. 16 Oct. 2019.

P

  1. Pafiti, A.

    1. Kostopanagiotou, G. G. et al "Desferrioxamine attenuates minor lung injury following surgical acute liver failure." European Respiratory Journal 33.6 (2009): 1429-1436. Web. 16 Oct. 2019.

  2. Pai, M.

    1. Lange, C. et al "Interferon-γ release assays for the diagnosis of active tuberculosis: sensible or silly?." European Respiratory Journal 33.6 (2009): 1250-1253. Web. 16 Oct. 2019.

  3. Panagopoulos, D.

    1. Kostopanagiotou, G. G. et al "Desferrioxamine attenuates minor lung injury following surgical acute liver failure." European Respiratory Journal 33.6 (2009): 1429-1436. Web. 16 Oct. 2019.

  4. Parambil, J. G.

    1. Maldonado, F. et al "Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage." European Respiratory Journal 33.6 (2009): 1361-1366. Web. 16 Oct. 2019.

  5. Parr, D. G.

    1. Dirksen, A. et al "Exploring the role of CT densitometry: a randomised study of augmentation therapy in α1-antitrypsin deficiency." European Respiratory Journal 33.6 (2009): 1345-1353. Web. 16 Oct. 2019.

  6. Pastorino, U.

    1. Sverzellati, N. et al "Sex differences in emphysema phenotype in smokers without airflow obstruction." European Respiratory Journal 33.6 (2009): 1320-1328. Web. 16 Oct. 2019.

  7. Peacock, A. J.

    1. McLure, L. E. R., and A. J. Peacock. "Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension." European Respiratory Journal 33.6 (2009): 1454-1466. Web. 16 Oct. 2019.

  8. Pecchiari, M.

    1. Pecchiari, M. et al "Effect of heliox breathing on flow limitation in chronic heart failure patients." European Respiratory Journal 33.6 (2009): 1367-1373. Web. 16 Oct. 2019.

  9. Peché, R.

    1. Michils, A. et al "Exhaled nitric oxide as a marker of asthma control in smoking patients." European Respiratory Journal 33.6 (2009): 1295-1301. Web. 16 Oct. 2019.

  10. Pedotti, A.

    1. Dellacà, R. L. et al "Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD." European Respiratory Journal 33.6 (2009): 1329-1337. Web. 16 Oct. 2019.

  11. Pellegrino, R.

    1. Barisione, G. et al "How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1." European Respiratory Journal 33.6 (2009): 1396-1402. Web. 16 Oct. 2019.

  12. Piitulainen, E.

    1. Dirksen, A. et al "Exploring the role of CT densitometry: a randomised study of augmentation therapy in α1-antitrypsin deficiency." European Respiratory Journal 33.6 (2009): 1345-1353. Web. 16 Oct. 2019.

  13. Plekker, D.

    1. Koegelenberg, C. F. N. et al "Diagnostic yield and safety of ultrasound-assisted biopsies in superior vena cava syndrome." European Respiratory Journal 33.6 (2009): 1389-1395. Web. 16 Oct. 2019.

  14. Pompilio, P. P.

    1. Dellacà, R. L. et al "Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD." European Respiratory Journal 33.6 (2009): 1329-1337. Web. 16 Oct. 2019.

  15. Pu, J-L.

    1. Jing, Z-C. et al "Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension." European Respiratory Journal 33.6 (2009): 1354-1360. Web. 16 Oct. 2019.

R

  1. Raby, B. A.

    1. Sharma, S. et al "Association of VEGF polymorphisms with childhood asthma, lung function and airway responsiveness." European Respiratory Journal 33.6 (2009): 1287-1294. Web. 16 Oct. 2019.

  2. Ramírez-Sarmiento, A. L.

    1. Marin-Corral, J. et al "Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients." European Respiratory Journal 33.6 (2009): 1309-1319. Web. 16 Oct. 2019.

  3. Randi, G.

    1. Sverzellati, N. et al "Sex differences in emphysema phenotype in smokers without airflow obstruction." European Respiratory Journal 33.6 (2009): 1320-1328. Web. 16 Oct. 2019.

  4. Reichert, C. L. A.

    1. Bathoorn, E. et al "A turbulent cause of bilateral pneumonia." European Respiratory Journal 33.6 (2009): 1513-1516. Web. 16 Oct. 2019.

  5. Reinmuth, N.

    1. Kreuter, M. et al "Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment." European Respiratory Journal 33.6 (2009): 1383-1388. Web. 16 Oct. 2019.

  6. Rooyackers, J.

    1. van Heemst, R. C. et al "Hypersensitivity pneumonitis caused by occupational exposure to phytase." European Respiratory Journal 33.6 (2009): 1507-1509. Web. 16 Oct. 2019.

  7. Roussos, C.

    1. Pecchiari, M. et al "Effect of heliox breathing on flow limitation in chronic heart failure patients." European Respiratory Journal 33.6 (2009): 1367-1373. Web. 16 Oct. 2019.

  8. Routsi, C.

    1. Kostopanagiotou, G. G. et al "Desferrioxamine attenuates minor lung injury following surgical acute liver failure." European Respiratory Journal 33.6 (2009): 1429-1436. Web. 16 Oct. 2019.

  9. Rubin, L. J.

    1. Opitz, C. F., and L. J. Rubin. "Acute vasodilator testing in idiopathic pulmonary arterial hypertension: must we take NO for the answer?." European Respiratory Journal 33.6 (2009): 1247-1249. Web. 16 Oct. 2019.

  10. Ryu, J. H.

    1. Maldonado, F. et al "Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage." European Respiratory Journal 33.6 (2009): 1361-1366. Web. 16 Oct. 2019.

S

  1. Sander, I.

    1. van Heemst, R. C. et al "Hypersensitivity pneumonitis caused by occupational exposure to phytase." European Respiratory Journal 33.6 (2009): 1507-1509. Web. 16 Oct. 2019.

  2. Saporiti, R.

    1. Barisione, G. et al "How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1." European Respiratory Journal 33.6 (2009): 1396-1402. Web. 16 Oct. 2019.

  3. Sato, A.

    1. Mato, N. et al "Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury." European Respiratory Journal 33.6 (2009): 1415-1428. Web. 16 Oct. 2019.

  4. Schaumburg, I.

    1. Jacobsen, G. et al "Increased incidence of respiratory symptoms among female woodworkers exposed to dry wood." European Respiratory Journal 33.6 (2009): 1268-1276. Web. 16 Oct. 2019.

  5. Schlünssen, V.

    1. Jacobsen, G. et al "Increased incidence of respiratory symptoms among female woodworkers exposed to dry wood." European Respiratory Journal 33.6 (2009): 1268-1276. Web. 16 Oct. 2019.

  6. Schneider, A.

    1. Hoeper, M. M. et al "Severe hepatitis associated with sitaxentan and response to glucocorticoid therapy." European Respiratory Journal 33.6 (2009): 1518-1519. Web. 16 Oct. 2019.

  7. Schubert, P.

    1. Koegelenberg, C. F. N. et al "Diagnostic yield and safety of ultrasound-assisted biopsies in superior vena cava syndrome." European Respiratory Journal 33.6 (2009): 1389-1395. Web. 16 Oct. 2019.

  8. Shaker, S. B.

    1. Dirksen, A. et al "Exploring the role of CT densitometry: a randomised study of augmentation therapy in α1-antitrypsin deficiency." European Respiratory Journal 33.6 (2009): 1345-1353. Web. 16 Oct. 2019.

  9. Sharma, S.

    1. Sharma, S. et al "Association of VEGF polymorphisms with childhood asthma, lung function and airway responsiveness." European Respiratory Journal 33.6 (2009): 1287-1294. Web. 16 Oct. 2019.

  10. Sigsgaard, T.

    1. Jacobsen, G. et al "Increased incidence of respiratory symptoms among female woodworkers exposed to dry wood." European Respiratory Journal 33.6 (2009): 1268-1276. Web. 16 Oct. 2019.

  11. Singhera, G. K.

    1. MacRedmond, R., G. K. Singhera, and D. R. Dorscheid. "Erythropoietin inhibits respiratory epithelial cell apoptosis in a model of acute lung injury." European Respiratory Journal 33.6 (2009): 1403-1414. Web. 16 Oct. 2019.

  12. Smyrniotis, V.

    1. Kostopanagiotou, G. G. et al "Desferrioxamine attenuates minor lung injury following surgical acute liver failure." European Respiratory Journal 33.6 (2009): 1429-1436. Web. 16 Oct. 2019.

  13. Soriano, J. B.

    1. Soriano, J. B., and M. Miravitlles. "Your racing horses will help you to quit: a lesson for COPD and α1-antitrypsin deficiency research." European Respiratory Journal 33.6 (2009): 1244-1246. Web. 16 Oct. 2019.

  14. Soto-Quiros, M. E.

    1. Sharma, S. et al "Association of VEGF polymorphisms with childhood asthma, lung function and airway responsiveness." European Respiratory Journal 33.6 (2009): 1287-1294. Web. 16 Oct. 2019.

  15. Spagnolo, P.

    1. Sverzellati, N. et al "Sex differences in emphysema phenotype in smokers without airflow obstruction." European Respiratory Journal 33.6 (2009): 1320-1328. Web. 16 Oct. 2019.

  16. Stockley, J. A.

    1. Dawkins, P. A. et al "Rate of progression of lung function impairment in α1-antitrypsin deficiency." European Respiratory Journal 33.6 (2009): 1338-1344. Web. 16 Oct. 2019.

  17. Stockley, R. A.

    1. Dawkins, P. A. et al "Rate of progression of lung function impairment in α1-antitrypsin deficiency." European Respiratory Journal 33.6 (2009): 1338-1344. Web. 16 Oct. 2019.
    2. Dirksen, A. et al "Exploring the role of CT densitometry: a randomised study of augmentation therapy in α1-antitrypsin deficiency." European Respiratory Journal 33.6 (2009): 1345-1353. Web. 16 Oct. 2019.

  18. Sugiyama, Y.

    1. Mato, N. et al "Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury." European Respiratory Journal 33.6 (2009): 1415-1428. Web. 16 Oct. 2019.

  19. Sundaram, S.

    1. Sundaram, S., A. D. Tasker, and N. W. Morrell. "Familial spontaneous pneumothorax and lung cysts due to a Folliculin exon 10 mutation." European Respiratory Journal 33.6 (2009): 1510-1512. Web. 16 Oct. 2019.

  20. Sverzellati, N.

    1. Sverzellati, N. et al "Sex differences in emphysema phenotype in smokers without airflow obstruction." European Respiratory Journal 33.6 (2009): 1320-1328. Web. 16 Oct. 2019.

  21. Sylvia, J. S.

    1. Sharma, S. et al "Association of VEGF polymorphisms with childhood asthma, lung function and airway responsiveness." European Respiratory Journal 33.6 (2009): 1287-1294. Web. 16 Oct. 2019.

T

  1. Tasker, A. D.

    1. Sundaram, S., A. D. Tasker, and N. W. Morrell. "Familial spontaneous pneumothorax and lung cysts due to a Folliculin exon 10 mutation." European Respiratory Journal 33.6 (2009): 1510-1512. Web. 16 Oct. 2019.

  2. Thomas, M.

    1. Kreuter, M. et al "Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment." European Respiratory Journal 33.6 (2009): 1383-1388. Web. 16 Oct. 2019.

  3. Tiesler, C.

    1. Derom, E. et al "Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma." European Respiratory Journal 33.6 (2009): 1277-1286. Web. 16 Oct. 2019.

  4. Tominaga, S.

    1. Mato, N. et al "Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury." European Respiratory Journal 33.6 (2009): 1415-1428. Web. 16 Oct. 2019.

  5. Torén, K.

    1. Modig, L. et al "Vehicle exhaust outside the home and onset of asthma among adults." European Respiratory Journal 33.6 (2009): 1261-1267. Web. 16 Oct. 2019.

  6. Torres, A.

    1. Woodhead, M. A., A. Torres, and S. Ewig. "Pigs might fly." European Respiratory Journal 33.6 (2009): 1241-1243. Web. 16 Oct. 2019.

V

  1. van den Heuvel, M. M.

    1. Koegelenberg, C. F. N. et al "Diagnostic yield and safety of ultrasound-assisted biopsies in superior vena cava syndrome." European Respiratory Journal 33.6 (2009): 1389-1395. Web. 16 Oct. 2019.

  2. van Heemst, R. C.

    1. van Heemst, R. C. et al "Hypersensitivity pneumonitis caused by occupational exposure to phytase." European Respiratory Journal 33.6 (2009): 1507-1509. Web. 16 Oct. 2019.

  3. Van Muylem, A.

    1. Michils, A. et al "Exhaled nitric oxide as a marker of asthma control in smoking patients." European Respiratory Journal 33.6 (2009): 1295-1301. Web. 16 Oct. 2019.

  4. Vlahakos, D.

    1. Kostopanagiotou, G. G. et al "Desferrioxamine attenuates minor lung injury following surgical acute liver failure." European Respiratory Journal 33.6 (2009): 1429-1436. Web. 16 Oct. 2019.

W

  1. Walker, P. P.

    1. Dellacà, R. L. et al "Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD." European Respiratory Journal 33.6 (2009): 1329-1337. Web. 16 Oct. 2019.

  2. Walker, T. D.

    1. Jobse, B. N. et al "Evaluation of allergic lung inflammation by computed tomography in a rat model in vivo." European Respiratory Journal 33.6 (2009): 1437-1447. Web. 16 Oct. 2019.

  3. Walters, S.

    1. Kampmann, B. et al "Interferon-γ release assays do not identify more children with active tuberculosis than the tuberculin skin test." European Respiratory Journal 33.6 (2009): 1374-1382. Web. 16 Oct. 2019.

  4. Wang, Y.

    1. Jing, Z-C. et al "Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension." European Respiratory Journal 33.6 (2009): 1354-1360. Web. 16 Oct. 2019.

  5. Ward, S. A.

    1. Whipp, B. J., and S. A. Ward. "Quantifying intervention-related improvements in exercise tolerance." European Respiratory Journal 33.6 (2009): 1254-1260. Web. 16 Oct. 2019.

  6. Watson, R. M.

    1. Davis, B. E. et al "Single-dose desloratadine and montelukast and allergen-induced late airway responses." European Respiratory Journal 33.6 (2009): 1302-1308. Web. 16 Oct. 2019.

  7. Weiss, S. T.

    1. Sharma, S. et al "Association of VEGF polymorphisms with childhood asthma, lung function and airway responsiveness." European Respiratory Journal 33.6 (2009): 1287-1294. Web. 16 Oct. 2019.

  8. Wencker, M.

    1. Dirksen, A. et al "Exploring the role of CT densitometry: a randomised study of augmentation therapy in α1-antitrypsin deficiency." European Respiratory Journal 33.6 (2009): 1345-1353. Web. 16 Oct. 2019.

  9. Whipp, B. J.

    1. Whipp, B. J., and S. A. Ward. "Quantifying intervention-related improvements in exercise tolerance." European Respiratory Journal 33.6 (2009): 1254-1260. Web. 16 Oct. 2019.

  10. Whittaker, E.

    1. Kampmann, B. et al "Interferon-γ release assays do not identify more children with active tuberculosis than the tuberculin skin test." European Respiratory Journal 33.6 (2009): 1374-1382. Web. 16 Oct. 2019.

  11. Williams, A.

    1. Kampmann, B. et al "Interferon-γ release assays do not identify more children with active tuberculosis than the tuberculin skin test." European Respiratory Journal 33.6 (2009): 1374-1382. Web. 16 Oct. 2019.

  12. Williams, B.

    1. Kampmann, B. et al "Interferon-γ release assays do not identify more children with active tuberculosis than the tuberculin skin test." European Respiratory Journal 33.6 (2009): 1374-1382. Web. 16 Oct. 2019.

  13. Wood, A. M.

    1. Dawkins, P. A. et al "Rate of progression of lung function impairment in α1-antitrypsin deficiency." European Respiratory Journal 33.6 (2009): 1338-1344. Web. 16 Oct. 2019.

  14. Woodhead, M. A.

    1. Woodhead, M. A., A. Torres, and S. Ewig. "Pigs might fly." European Respiratory Journal 33.6 (2009): 1241-1243. Web. 16 Oct. 2019.

  15. Wright, C. A.

    1. Koegelenberg, C. F. N. et al "Diagnostic yield and safety of ultrasound-assisted biopsies in superior vena cava syndrome." European Respiratory Journal 33.6 (2009): 1389-1395. Web. 16 Oct. 2019.

  16. Wu, Y.

    1. Jing, Z-C. et al "Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension." European Respiratory Journal 33.6 (2009): 1354-1360. Web. 16 Oct. 2019.

X

  1. Xu, X-Q.

    1. Jing, Z-C. et al "Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension." European Respiratory Journal 33.6 (2009): 1354-1360. Web. 16 Oct. 2019.

Y

  1. Yang, Y-J.

    1. Jing, Z-C. et al "Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension." European Respiratory Journal 33.6 (2009): 1354-1360. Web. 16 Oct. 2019.

  2. Yi, E. S.

    1. Maldonado, F. et al "Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage." European Respiratory Journal 33.6 (2009): 1361-1366. Web. 16 Oct. 2019.

Z

  1. Zompatori, M.

    1. Sverzellati, N. et al "Sex differences in emphysema phenotype in smokers without airflow obstruction." European Respiratory Journal 33.6 (2009): 1320-1328. Web. 16 Oct. 2019.
Back to top
European Respiratory Journal: 33 (6)

Search Within This Issue

Jump to

Manage Table of content Alerts